cvs caremark semaglutide is adding Zepbound, Eli Lilly's obesity drug, back to its commercial insurance plan formularies, more than a year after it stopped covering it in favor of Novo Nordisk's Wegovy. MORE CVS Caremark adds Zepbound back

High TSH level within normal range is associated with obesity, dyslipidemia, hypertension, inflammation, hypercoagulability, and the metabolic syndrome: A novel cardiometabolic marker

That means you might have a bigger appetite, and you may feel hungry again more quickly after a meal

With the rise in the number of patients being affected by these disorders worldwide, there will be a corresponding rise in demand for more patient-friendly drug delivery devices like autoinjectors and pen injectors

People who want body composition change, not just scale weight: since the peptide acts on fat metabolism, the relevant measure is body composition over time

Efficient initiation of HCV RNA replication in cell culture